1 / 18

Pandemic Influenza Vaccine Priority Groups: Data Reporting

This presentation by Dr. Tom Shimabukuro from the CDC discusses the implementation plan for the National Strategy for Pandemic Influenza, focusing on the tracking of vaccine coverage and adverse events. It outlines the strategic goals, including the establishment of a pre-pandemic vaccine stockpile and the assurance that every U.S. citizen receives pandemic vaccine timely. The presentation also details priority groups for vaccination, the phases of vaccination, and the CDC’s plans for monitoring vaccine utilization, making it crucial for public health stakeholders in pandemic preparedness.

cooper
Télécharger la présentation

Pandemic Influenza Vaccine Priority Groups: Data Reporting

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Pandemic Influenza Vaccine Priority Groups:Data Reporting Pandemic Influenza Vaccine: Doses Administered and Safety Training Conference Tom Shimabukuro, MD, MPH, MBA Immunization Services Division Centers for Disease Control and Prevention (CDC) August 21, 2008

  2. Implementation Plan for the National Strategy (May 2006) • 300(+) actions for Federal Departments/Agencies HSC Action Item 6.1.13.9 • “HHS in coordination with … shall develop/refine mechanisms to … track vaccine and antiviral medication coverage and adverse events …”

  3. HHS Pandemic Influenza Plan (Nov 2005) • Part 1: HHS strategic plan • Part 2: Public health guidance for state and local partners • Part 3: HHS Agencies’ operational plans (in development) • Updates • March 2006 • June 2006 • November 2006

  4. CDC pandemic plans

  5. CDC pandemic plans: monitoring vaccine utilization • CDC Influenza Pandemic Operation Plan (OPLAN) • ISD Influenza Pandemic Operation Plan (OPLAN) “… develop plans to monitor pre-pandemic and pandemic influenza vaccine doses administered through the CDC’s Countermeasure and Response Administration system (CRA).” “Develop plans for using population-based surveys to obtain national and State-level pandemic influenza vaccine coverage estimates …”

  6. U.S. Pan Flu Vaccine Strategic Current & Possible New Goals • Vaccines • Goal #1: Establish and maintain a dynamic pre-pandemic influenza vaccine stockpile available for 20 M persons (2 doses/person) or more persons depending on vaccine mfg. capacity & results of dose-sparing adjuvant studies and prime-boost immunization studies: H5N1 vaccine stockpiles • Goal #2: Provide pandemic vaccine to all U.S. citizens within 6 months of a pandemic declaration: pandemic vaccine (600 M doses) National Strategy for Pandemic Influenza (Nov 2005) and HHS Pandemic Influenza Plan (Nov 2005) www.pandemicflu.gov Courtesy Robin Robinson, PhD, Director – BARDA (ASPR/HHS)

  7. U.S. Pan Flu Vaccine Capacity Forecast: Antigen Alone Vaccines 2010 Cell-capacity Effect #1 2011 Cell-capacity Effect #2 2009 Egg-capacity Effect #2 2008 Egg-capacity Effect #1 Courtesy Robin Robinson, PhD, Director – BARDA (ASPR/HHS)

  8. http://www.pandemicflu.gov/vaccine/allocationguidance.pdf

  9. Switch to PDF file

  10. On PDF file

  11. On PDF file

  12. Switch off PDF file

  13. 14 priority group “buckets” • Homeland and national security Tiers 1-3 • 3 buckets • Health care and community support services Tiers 1-3 • 3 buckets • Critical infrastructure Tiers 1-3 • 3 buckets • General population Tiers 1-5 • 5 buckets

  14. Vaccination periods Take into account both timing and supply: • Preparation period • Pre-pandemic influenza vaccination period • Manufacturing period • Early pandemic influenza vaccination period • Later pandemic influenza vaccination period

  15. Questions?

  16. The findings and conclusions in this presentation have not been formally disseminated by CDC and should not be construed to represent any agency determination or policy.

More Related